Shimmick Corporation heads into its May 14 earnings with a bruised chart and a notable insider selling pattern that frames the setup.
The stock closed at $4.68 on Monday — an 18.75% single-day drop — and is down nearly 11% over the past week. That reverses a strong 19% one-month gain, suggesting the recent rally brought sellers to the table rather than confidence. The most prominent of those sellers has been Executive Chairman Mitchell Goldsteen, who trimmed 125,000 shares in mid-March at $2.86. He holds 57.8% of shares outstanding, so the position remains dominant, but the direction of travel matters: a chairman reducing exposure ahead of a print is a signal worth noting.
CFO Todd Yoder also sold roughly 38,700 shares on April 14, at $3.91, in the same reporting window. Both trades came alongside stock awards, suggesting partial liquidity events rather than outright bearish declarations — but combined, net insider activity over the past 90 days shows $508,927 in net sales, tilting the insider tape toward distribution.
Short positioning does little to explain the Monday selloff. SI % of FF is essentially negligible at 0.07% of free float. The ORTEX short score reads 26.2, sitting in the 91st percentile for its sector — but this reflects relative scoring, not an absolute short squeeze setup. Borrow availability is effectively unlimited, with ORTEX reporting availability at the maximum reading. Cost to borrow is a modest ~5%, and has been relatively stable across the past six weeks. The lending market is telling a quiet story.
The analyst bench is thin: two buy ratings, no holds, no sells, with a mean price target of $5.50 against Friday's close of $4.68. That implies roughly 17% upside on consensus — but the analyst data is approximately 60 days old and reflects a print issued in March. No recent rating changes have crossed. Given the stock's volatile price action, treat those targets as directional context rather than precise anchors.
What the May 14 print will test is whether the underlying construction and engineering backlog justifies a valuation that has swung between $2.80 and $6.67 in just three months — and whether management's guidance narrative can arrest a momentum reversal that arrived, sharply, on the eve of results.
See the live data behind this article on ORTEX.
Open SHIM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
